New York State Assemblyman Eric Stevenson visits ADMS affiliate, New York Renal Associates
May 6, 2011
BRONX – New York State Assemblyman Eric Stevenson (79th District, Bronx County) was recently invited to tour New York Renal Associates, a network affiliate of Atlantic Dialysis Management Services (ADMS), as well as meet with staff and management to discuss legislative issues relating to health care and the state health care plan.
Dr. J. Ganesh Bhat, co-principal of ADMS and Mayette Casco, both Vice Presidents with ADMS; Ron Pascual, administrator of New York Renal Associates; Josep Adalla, administrator of the Daughters of Jacob Nursing Home in the Bronx and Ricardo Sime, External Relations Liaison with ADMS, were among those who attended the meeting with Assemblyman Stevenson. Dr. Bhat led the assemblyman on a tour of the dialysis center facility prior to the meeting.
Assemblyman Stevenson was elected to the New York State Assembly in 2010 and follows in the footsteps of his father, former District Leader Edward Stevenson, Jr., and his grandfather, former Assemblyman Edward Stevenson, Sr, by serving in Bronx Community Board 3 under the administrations of Bronx borough presidents Fernando Ferrer and Adolfo Carrion, Jr..
“It was a pleasure to meet with the Assemblyman today. We gained valuable insight discussing some of the legislative issues that affect the dialysis center and its staff. We had a productive talk about how the state’s budget will affect health care,” said Mr. Cundiff, Vice President of External Relations and Regulatory Affairs of ADMS.
Atlantic Dialysis Management Services, LLC (ADMS) provides new dialysis site development, day to day administration and management of dialysis services and related business development activities. Its business strategy is to produce economies of scale and maximize individual site results through consolidated activities. Central to the ADMS approach is the long term control of clinical services by nephrologists. In 2010, ADMS affiliates provided over 225,000 dialysis treatments to over 2,500 patients in New York City and Long Island.